Abstract
The first immunotoxins (ITs) assembled by Moolten et al. in the seventies [1, 2] were composed of antibodies linked to whole toxins such as diphtheria toxin and ricin. In order to circumvent the nonspecific binding due to the B chains, ITs with the A chain subunit of the polypeptide toxin ricin were constructed [3–11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Moolten, F.L., and Cooperband, S.R. (1970) Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells. Science, 169, 68–70.
Moolten, F.L., Zajdel, S., Cooperband, S.R. (1976) Immuno-therapy of experimental animal tumors with antitumor antibodies conjugated to diphtheria toxin or ricin. Ann. N. Y. Acad. Sci., 277, 690–699.
French Patent (1978) n° 2437213. US Patent (1982) n° 4340535.
Jansen F.K., Blythman, H.E., Carriere, D., Casellas, P., Diaz, J., Gros, P., Hennequin, J.R., Paolucci, F., Pau, B., Poncelet, R., Richer, G., Salhi, S.L., Vidal, H., and Voisin, G.A. (1980) High specific cytotoxicity of antibody-toxin hybrid molecules (immuntoxins) for target cells. Immunol. Letters, 2, 97–102.
Blythman, H.E., Casellas, P., Gros, P., Jansen, F.K., Paolucci, F., Pau, B., and Vidal, H. (1981) Immunotoxins: Hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature, 290 (5802), 145–146.
Jansen, F.K., Blythman, H.E., Carrière, D., Casellas, P., Gros, O., Gros, P., Laurent, J.C., Paolucci, F., Pau, B., Poncelet, P., Richer, G., Vidal, H., and Voisin, G.A. (1982) Immunotoxins: Hybrid molecules combining high specificity and potent cytotoxicity. Immunol. Rev., 62, 185–216.
Krolick, K.A., Villemez, C., Isakson, P., Uhr, J.W., and Vitetta, E.S. (1980) Selective killing of normal or neoplastic B-cells by antibodies coupled to the A-chain of ricin. Proc. Natl. Acad. Sci. USA, 77, 5419–5423.
Masuho, Y., and Hara, T. (1980) Target-cell cytotoxicity of a hybrid of Fab’ of immunoglobulin and A-chain of ricin. Gann, 71, 759–765.
Raso, V., and Griffin, T. (1980) Specific cytotoxicity of a human immunoglobulin-directed Fab’-ricin A-chain conjugate. J. Immunol., 125, 2610–2616.
Gilliland, D.G., Steplewski, Z., Collier, R.J., Mitchell, K.F., Tong, H.C., and Koprowski, H. (1980) Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A-chains to colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA, 77, 4539–4543.
Masuho, Y., Kishida, K., Saito, M., Umemoto, N., and Hara, T. (1982) Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody. J. Biochem., 91, 1583–1591.
Nicolson, G., and Blaustein, J. (1972) The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces. Biochim. Biophys. Acta., 266, 543–547.
Olsnes, S.S., Saltvedt, E., and Phil, A. (1974) Isolation and comparison of galactose binding lectins from Abrus precatorius and Ricinus communis. J. Biol. Chem., 249, 803–810.
Refsnes, K., Haylett, T., Sandvig, K., and Olsnes, S. (1977) Modeccin — a plant toxin inhibiting protein. Biochem. Biophys Res. Commun., 79, 1176–1183.
Irvin, J., Kelly, T., and Robertus, J. (1980) Purification and properties of a second antiviral protein from Phytolaacca americana which inactivates eukaryotic ribosomes. Arch. Biochem. Biophys., 200, 418–425.
Stirpe, R., Olsnes, S., and Pihl, A. (1980) Gelonin, a new inhibitor of protein synthesis, non-toxic to intact cells. J. Biol. Chem., 255, 6947–6952.
Youle, R.J., and Neville, D.M. (1982) Kinetics of protein synthesis inactivation by ricinanti-Thy 1.1 monoclonal antibody hybrids — Role of the ricin B subunit demonstrated by reconstitution. J. Biol. Chem., 257 (4), 1598–1601.
Maclntosh, D.P., Edwards, D.C., Cumber, A.J., Parnell, G.D., Dean, C.J., Ross, W.C., and Forrester, J.A. (1983) Ricin B-chain converts a noncytotoxic antibody-ricin A-chain conjugate into a potent and specific cytotoxic agent. FEBS, Lett 164, 17–20.
Vitetta, E.S., Fulton, R.J., and Uhr, J.W. (1984) Cytotoxicity of a cell-reactive immunotoxin containing ricin A-chain is potentiated by an anti-immunotoxin containing ricin B-chain. J. Exp. Med., 160, 341–346.
Vitetta, E.S. (1986) Synergy between immunotoxins prepared with native ricin A-chains and chemically-modified ricin B-chains. J. of Immunol., 136 (5), 1880–1883.
Nanno, S., Ishuguro, M., Funatsu, G., and Funatsu, M. (1975) Isolation of glycopeptides from ricin D. Agri. Biol. Chem., 39 (8), 1645–1650.
Bourrie, B.J., Casellas, P., Blythman, H.E., and Jansen, F.K. (1986) Study of the plasma clearance of antibody-ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A-chain that mediate rapid clearance of the immunotoxin. Eur. J. Biochem., 155, 1–10.
Blakey, D.C., and Thorpe, P.E. (1986) Effect of chemical deglycosylation on the in vivo fate of ricin A-chain. Cancer Drug Delivery, 3, 189–196.
Worrell, N.R., Skilleter, D.N., Cumber, A.J., and Price, R.J. (1986) Mannose receptor dependent uptake of a ricin A-chain antibody conjugate by rat liver non-parenchymal cells. Biochem. and Biophys. Res. Commun., 137, 892–896.
Simmons, B.M., Stahl, P.D., and Russel, J.H. (1986) Mannose receptor-mediated uptake of ricin toxin and ricin A-chain by macrophages. Multiple intracellular pathways for A-chain translocation. J. Biol. Chem., 261, 7916–7920.
European patent applications (1985) n°0172045 and 0192002.
Casellas, P., Bourrie, B., Canat, X., Blythman, H.E., and Jansen, F.K. (1987) Pharmacology of antibody-ricin A-chain immunotoxins. In: Membrane Mediated Cytotoxicity. U. C. L.A. Symposia, Alan R. Liss, pp 185–193.
Lewis, M.S., and Youle, R.J. (1986) Ricin subunit association. Thermodynamics and the role of the disulfide bond in toxicity. J. Biol. Chem., 261 (25), 11571.
Foxwell, B.M.J., Donovan, T.A., Thorpe, P.E., and Wilson, F. (1985) The removal of carbohydrates from ricin with endoglycosidases H, D and D and alpha mannosidases. Biochim. Biophys. Acta, 840, 193–203.
Vidal, H., Casellas, P., Gros, P., and Jansen, F.K. (1985) Studies on components of immunotoxins: Purification of ricin and its subunits and influence of unreacted antibodies. Int. J. Cancer, 36, 705–711.
Laurent, G., Pris, J., Farcet, J.P., Carayon, P., Blythman, H.E., Casellas, P., Poncelet, P., and Jansen, F.K. (1986) Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients. Blood, 67, 1680–1687.
Thorpe, P.E., Detre, S.I., Foxwell, B.M., Brown, A.N.F., Skilleter, D.N., Wilson, G., Forrester, J.A., and Stirpe, F. (1985) Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixture. Eur. J. Biochem., 14, 197–206.
European patent application (1985) n°0169111.
Taira, E., Yoshizuma, N., Funatsu, G., and Funatsu, M. (1978) Effects of physical and chemical treatments on the biological activity of ricin D. Agric. Biol. Chem., 42(10), 1927.
Riordan, J.F., and Vallee, B.L. (1967) Acetylation. In: Methods in Enzymology, Vol. 11. C.H. Hirs, ed. Academic Press, New York and London, pp 565–570.
Riordan, J.F., Wacker, W.E., and Vallee, B.L. (1965) N-acetyl imidazole: A reagent for determination of free tyrosyl residues of proteins. Biochemistry, 4, 1758.
Gros, O., Gros, P., Jansen, F.K., and Vidal, H. (1985) Biochemical aspects of immunotoxin preparation. J. Immunol. Methods, 81, 283–297.
Raso, V., and Lawrence, J. (1984) Carboxylic ionophores enhance the cytotoxic potency of ligand and antibody delivered ricin A-chain. J. Exp. Med., 160, 1234–1240.
Casellas, P., Bourrie, B.J., Gros, P., and Jansen, F.K. (1984) Kinetics of cytotoxicity induced by immunotoxins: Enhancement by lysomotropic amines and carboxylic ionophores. J. Biol. Chem., 259, 9359–9364.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Jansen, F.K. et al. (1988). Toxin selection and modification: Utilization of the A chain of ricin. In: Frankel, A.E. (eds) Immunotoxins. Cancer Treatment and Research, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1083-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1083-9_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8419-2
Online ISBN: 978-1-4613-1083-9
eBook Packages: Springer Book Archive